Related Experiment Video
Updated: Aug 21, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Clinical characteristics and mortality risk prediction model in children with acute myocarditis
Shi-Xin Zhuang1, Peng Shi2, Han Gao1
1Children's Hospital of Fudan University, 399 Wan Yuan Road, Shanghai, 201102, China.
Insights
Researchers identified key risk factors for acute myocarditis (AMC) in children and developed a prediction model. The Acute Myocarditis Death Risk Score (AMCDRS) can help identify high-risk pediatric patients upon hospital admission.
Area of Science:
- Pediatric Cardiology
- Critical Care Medicine
- Biostatistics
Background:
- Acute myocarditis (AMC) poses significant mortality risks in pediatric populations.
- Early identification of high-risk children is crucial for timely intervention and improved outcomes.
Purpose of the Study:
- To identify risk factors associated with mortality in pediatric AMC.
- To develop and validate a predictive model for in-hospital mortality in children with AMC at the time of hospital admission.
Main Methods:
- A retrospective cohort study was conducted on 67 pediatric patients diagnosed with AMC.
- Data collected included demographics, clinical presentation, AMC type, and laboratory results.
- Bayesian model averaging and Hosmer-Lemeshow tests were used to develop the Acute Myocarditis Death Risk Score (AMCDRS).
Main Results:
- The study identified 10 variables contributing to the AMCDRS, including male sex, fever, congestive heart failure, low ejection fraction, pulmonary edema, ventricular tachycardia, elevated lactic acid, fulminant myocarditis, abnormal creatine kinase-MB, and hypotension.
- The developed AMCDRS demonstrated good discrimination (AUC of 0.781) and acceptable calibration in the validation cohort.
- Digestive disorder was the most common presenting symptom (67.2%).
Conclusions:
- Several clinical and laboratory factors are significantly associated with increased mortality in pediatric AMC.
- The AMCDRS provides a valuable tool for clinicians to assess mortality risk in children with AMC at hospital admission.
Background:
Acute myocarditis (AMC) can cause poor outcomes or even death in children. We aimed to identify AMC risk factors and create a mortality prediction model for AMC in children at hospital admission.
Methods:
This was a single-center retrospective cohort study of AMC children hospitalized between January 2016 and January 2020. The demographics, clinical examinations, types of AMC, and laboratory results were collected at hospital admission. In-hospital survival or death was documented. Clinical characteristics associated with death were evaluated.
Results:
Among 67 children, 51 survived, and 16 died. The most common symptom was digestive disorder (67.2%). Based on the Bayesian model averaging and Hosmer-Lemeshow test, we created a final best mortality prediction model (acute myocarditis death risk score, AMCDRS) that included ten variables (male sex, fever, congestive heart failure, left-ventricular ejection fraction < 50%, pulmonary edema, ventricular tachycardia, lactic acid value > 4, fulminant myocarditis, abnormal creatine kinase-MB, and hypotension). Despite differences in the characteristics of the validation cohort, the model discrimination was only marginally lower, with an AUC of 0.781 (95% confidence interval = 0.675-0.852) compared with the derivation cohort. Model calibration likewise indicated acceptable fit (Hosmer‒Lemeshow goodness-of-fit, P¼ = 0.10).
Conclusions:
Multiple factors were associated with increased mortality in children with AMC. The prediction model AMCDRS might be used at hospital admission to accurately identify AMC in children who are at an increased risk of death.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Myocarditis I: Introduction
Myocarditis IV: Nursing Management
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

